| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $129.4M | +29.9% |
| Cost of Revenue | $46.2M | +21.6% |
| Gross Profit | $83.2M | +35.1% |
| R&D Expense | $6.3M | +5.2% |
| SG&A Expense | $27.1M | +47.2% |
| Operating Income | $16.3M | +110.7% |
| Pre-tax Income | $18.2M | +105.4% |
| Income Tax | $810K | +165.6% |
| Net Income | $17.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $9.7M | +25.4% |
| Inventory | $20.4M | +122.2% |
| Current Assets | $96.8M | +51.0% |
| Total Assets | $106.4M | +55.8% |
| Current Liabilities | $19.9M | +11.0% |
| Total Liabilities | $29.9M | +34.7% |
| Stockholders' Equity | $76.5M | +66.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13.5M | +11.5% |
| Investing Cash Flow | -$292K | -104.2% |
| Financing Cash Flow | $6.9M | +28.8% |
| +103.3% |
| EPS (Basic) | $0.22 | +100.0% |
| EPS (Diluted) | $0.20 | +81.8% |